ATP Inks Michelob Ultra Deal In U.S. Adidas Restructures Reebok Management Reebok Seeks To Blend Shopping, Fitness Reebok's Fitness Focus Paying Off Anheuser-Busch Renews Cubs Deal Corona Logo Taken Off ATP Tourney Nets Reebok Cap Measures Impacts To Athletes' Heads Bud Signs Deal With SHR To Stay With Harvick Tony Stewart Promotes Coke Zero 400 Budweiser, NHLPA Ink Deal
SBD/6/Sponsorships Advertising Marketing
COMPANY WATCH: COORS SLUMPS, COKE SIGNS UP, REEBOK PROFILE
Published July 6, 1995
In the current FORTUNE, Eric Schonfeld writes that "about the only thing Adolph Coors can do to make Wall Street change its tepid outlook on the stock is, as one industry observer puts it, 'discover a cure for cancer.'" Second quarter earnings per share fell $.40 from $.63 during the same period last year. "Costlier aluminum cans and stiffer pricing are guzzling profits." Coors is "a distant third behind" A-B, and Miller in an industry "unlikely to grow more than 1% this year," and Beer Marketer's Insight reports that Coors' market share has remained "stalled" at 10%. Schonfeld: "Coors needs a hit" (FORTUNE, 7/27). COKE SIGNS A BLOCKBUSTER: Blockbuster Entertainment has formed an agreement for exclusive rights to Coca-Cola soft drinks at all Blockbuster Entertainment locations worldwide for a five- year period (AD AGE ONLINE, 7/6). REEBOK: Reebok is the focus of USA TODAY's "Company Spotlight." Although the company has "been caught flat-footed in the athletic shoe market," Liz Green writes that "shoes will be introduced at a faster pace and tie with Reebok apparel lines to create a stronger retail presence." While trying to cut costs, Reebok acknowledges the need to spend more on ads and product development (USA TODAY, 7/6).